Mahrukh Huseni
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 15
- Cancer Diagnosis and Treatment 3
-
- Renal cell carcinoma treatment 15
- Ferroptosis and cancer prognosis 3
- Co-authors
- Xin Yu (1 shared paper)Jason A. Hackney (2 shared papers)Dan Eaton (2 shared papers)Jane L. Grogan (2 shared papers)Bryan Irving (1 shared paper)Summer Park (2 shared papers)Laëtitia Comps‐Agrar (2 shared papers)Robert J. Johnston (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Journal for ImmunoTherapy of Cancer (4 papers)Annals of Oncology (4 papers)Cancer Research (3 papers)European Journal of Cancer (2 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Mahrukh Huseni
30 papers receiving 1.6k citations
Mahrukh Huseni's Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 958
- Immunology 739
- Pulmonary and Respiratory Medicine 511
- Cancer Research 170
- Molecular Biology 275
Countries citing papers authored by Mahrukh Huseni
This map shows the geographic impact of Mahrukh Huseni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahrukh Huseni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahrukh Huseni more than expected).
Fields of papers citing papers by Mahrukh Huseni
This network shows the impact of papers produced by Mahrukh Huseni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahrukh Huseni. The network helps show where Mahrukh Huseni may publish in the future.
Co-authors
The 25 scholars most cited alongside Mahrukh Huseni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function Hit paper breakdown → | 2014 | 910 |
| 2 | 2018 | 154 | |
| 3 | 2021 | 111 | |
| 4 | 2020 | 63 | |
| 5 | 2018 | 61 | |
| 6 | 2017 | 59 | |
| 7 | 2017 | 59 | |
| 8 | 2016 | 56 | |
| 9 | 2018 | 38 | |
| 10 | 2016 | 35 | |
| 11 | 2019 | 26 | |
| 12 | 2018 | 17 | |
| 13 | 2025 | 14 | |
| 14 | 2017 | 11 | |
| 15 | 2017 | 10 | |
| 16 | 2013 | 8 | |
| 17 | 2017 | 7 | |
| 18 | 2008 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2021 | 4 |
About Mahrukh Huseni
Mahrukh Huseni is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Surgery, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (15 papers), Cancer Immunotherapy and Biomarkers (15 papers), Cancer Genomics and Diagnostics (7 papers), Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (958 citations), Immunology (739 citations), Pulmonary and Respiratory Medicine (511 citations), Cancer Research (170 citations) and Molecular Biology (275 citations). Mahrukh Huseni has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Xin Yu, Jason A. Hackney, Dan Eaton, Jane L. Grogan, Bryan Irving, Summer Park, Laëtitia Comps‐Agrar, Robert J. Johnston, Yagai Yang and Henry Chiu. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Annals of Oncology, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.